name stringlengths 11 253 |
|---|
### Human: Subacute thyroiditis### Assistant: 2451 |
### Human: Chronic lymphocytic thyroiditis### Assistant: 2452 |
### Human: Chronic fibrous thyroiditis### Assistant: 2453 |
### Human: Iatrogenic thyroiditis### Assistant: 2454 |
### Human: Other and unspecified chronic thyroiditis### Assistant: 2458 |
### Human: Thyroiditis, unspecified### Assistant: 2459 |
### Human: Disorders of thyrocalcitonin secretion### Assistant: 2460 |
### Human: Dyshormonogenic goiter### Assistant: 2461 |
### Human: Cyst of thyroid### Assistant: 2462 |
### Human: Hemorrhage and infarction of thyroid### Assistant: 2463 |
### Human: Other specified disorders of thyroid### Assistant: 2468 |
### Human: Unspecified disorder of thyroid### Assistant: 2469 |
### Human: Secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified### Assistant: 24900 |
### Human: Secondary diabetes mellitus without mention of complication, uncontrolled### Assistant: 24901 |
### Human: Secondary diabetes mellitus with ketoacidosis, not stated as uncontrolled, or unspecified### Assistant: 24910 |
### Human: Secondary diabetes mellitus with ketoacidosis, uncontrolled### Assistant: 24911 |
### Human: Secondary diabetes mellitus with hyperosmolarity, not stated as uncontrolled, or unspecified### Assistant: 24920 |
### Human: Secondary diabetes mellitus with hyperosmolarity, uncontrolled### Assistant: 24921 |
### Human: Secondary diabetes mellitus with other coma, not stated as uncontrolled, or unspecified### Assistant: 24930 |
### Human: Secondary diabetes mellitus with other coma, uncontrolled### Assistant: 24931 |
### Human: Secondary diabetes mellitus with renal manifestations, not stated as uncontrolled, or unspecified### Assistant: 24940 |
### Human: Secondary diabetes mellitus with renal manifestations, uncontrolled### Assistant: 24941 |
### Human: Secondary diabetes mellitus with ophthalmic manifestations, not stated as uncontrolled, or unspecified### Assistant: 24950 |
### Human: Secondary diabetes mellitus with ophthalmic manifestations, uncontrolled### Assistant: 24951 |
### Human: Secondary diabetes mellitus with neurological manifestations, not stated as uncontrolled, or unspecified### Assistant: 24960 |
### Human: Secondary diabetes mellitus with neurological manifestations, uncontrolled### Assistant: 24961 |
### Human: Secondary diabetes mellitus with peripheral circulatory disorders, not stated as uncontrolled, or unspecified### Assistant: 24970 |
### Human: Secondary diabetes mellitus with peripheral circulatory disorders, uncontrolled### Assistant: 24971 |
### Human: Secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified### Assistant: 24980 |
### Human: Secondary diabetes mellitus with other specified manifestations, uncontrolled### Assistant: 24981 |
### Human: Secondary diabetes mellitus with unspecified complication, not stated as uncontrolled, or unspecified### Assistant: 24990 |
### Human: Secondary diabetes mellitus with unspecified complication, uncontrolled### Assistant: 24991 |
### Human: Letterer-siwe disease, lymph nodes of head, face, and neck### Assistant: 20251 |
### Human: Letterer-siwe disease, intrathoracic lymph nodes### Assistant: 20252 |
### Human: Letterer-siwe disease, intra-abdominal lymph nodes### Assistant: 20253 |
### Human: Letterer-siwe disease, lymph nodes of axilla and upper limb### Assistant: 20254 |
### Human: Letterer-siwe disease, lymph nodes of inguinal region and lower limb### Assistant: 20255 |
### Human: Letterer-siwe disease, intrapelvic lymph nodes### Assistant: 20256 |
### Human: Letterer-siwe disease, spleen### Assistant: 20257 |
### Human: Letterer-siwe disease, lymph nodes of multiple sites### Assistant: 20258 |
### Human: Malignant mast cell tumors, unspecified site, extranodal and solid organ sites### Assistant: 20260 |
### Human: Malignant mast cell tumors, lymph nodes of head, face, and neck### Assistant: 20261 |
### Human: Malignant mast cell tumors, intrathoracic lymph nodes### Assistant: 20262 |
### Human: Malignant mast cell tumors, intra-abdominal lymph nodes### Assistant: 20263 |
### Human: Malignant mast cell tumors, lymph nodes of axilla and upper limb### Assistant: 20264 |
### Human: Malignant mast cell tumors, lymph nodes of inguinal region and lower limb### Assistant: 20265 |
### Human: Malignant mast cell tumors, intrapelvic lymph nodes### Assistant: 20266 |
### Human: Malignant mast cell tumors, spleen### Assistant: 20267 |
### Human: Malignant mast cell tumors, lymph nodes of multiple sites### Assistant: 20268 |
### Human: Peripheral T cell lymphoma, unspecified site, extranodal and solid organ sites### Assistant: 20270 |
### Human: Peripheral T cell lymphoma, lymph nodes of head, face, and neck### Assistant: 20271 |
### Human: Peripheral T cell lymphoma, intrathoracic lymph nodes### Assistant: 20272 |
### Human: Peripheral T cell lymphoma, intra-abdominal lymph nodes### Assistant: 20273 |
### Human: Peripheral T cell lymphoma, lymph nodes of axilla and upper limb### Assistant: 20274 |
### Human: Peripheral T cell lymphoma, lymph nodes of inguinal region and lower limb### Assistant: 20275 |
### Human: Peripheral T cell lymphoma, intrapelvic lymph nodes### Assistant: 20276 |
### Human: Peripheral T cell lymphoma, spleen### Assistant: 20277 |
### Human: Peripheral T cell lymphoma, lymph nodes of multiple sites### Assistant: 20278 |
### Human: Other malignant lymphomas, unspecified site, extranodal and solid organ sites### Assistant: 20280 |
### Human: Other malignant lymphomas, lymph nodes of head, face, and neck### Assistant: 20281 |
### Human: Other malignant lymphomas, intrathoracic lymph nodes### Assistant: 20282 |
### Human: Other malignant lymphomas, intra-abdominal lymph nodes### Assistant: 20283 |
### Human: Other malignant lymphomas, lymph nodes of axilla and upper limb### Assistant: 20284 |
### Human: Other malignant lymphomas, lymph nodes of inguinal region and lower limb### Assistant: 20285 |
### Human: Other malignant lymphomas, intrapelvic lymph nodes### Assistant: 20286 |
### Human: Other malignant lymphomas, spleen### Assistant: 20287 |
### Human: Other malignant lymphomas, lymph nodes of multiple sites### Assistant: 20288 |
### Human: Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, unspecified site, extranodal and solid organ sites### Assistant: 20290 |
### Human: Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of head, face, and neck### Assistant: 20291 |
### Human: Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intrathoracic lymph nodes### Assistant: 20292 |
### Human: Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intra-abdominal lymph nodes### Assistant: 20293 |
### Human: Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of axilla and upper limb### Assistant: 20294 |
### Human: Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of inguinal region and lower limb### Assistant: 20295 |
### Human: Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intrapelvic lymph nodes### Assistant: 20296 |
### Human: Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, spleen### Assistant: 20297 |
### Human: Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of multiple sites### Assistant: 20298 |
### Human: Multiple myeloma, without mention of having achieved remission### Assistant: 20300 |
### Human: Multiple myeloma, in remission### Assistant: 20301 |
### Human: Multiple myeloma, in relapse### Assistant: 20302 |
### Human: Plasma cell leukemia, without mention of having achieved remission### Assistant: 20310 |
### Human: Plasma cell leukemia, in remission### Assistant: 20311 |
### Human: Plasma cell leukemia, in relapse### Assistant: 20312 |
### Human: Other immunoproliferative neoplasms, without mention of having achieved remission### Assistant: 20380 |
### Human: Other immunoproliferative neoplasms, in remission### Assistant: 20381 |
### Human: Other immunoproliferative neoplasms, in relapse### Assistant: 20382 |
### Human: Acute lymphoid leukemia, without mention of having achieved remission### Assistant: 20400 |
### Human: Acute lymphoid leukemia, in remission### Assistant: 20401 |
### Human: Acute lymphoid leukemia, in relapse### Assistant: 20402 |
### Human: Chronic lymphoid leukemia, without mention of having achieved remission### Assistant: 20410 |
### Human: Chronic lymphoid leukemia, in remission### Assistant: 20411 |
### Human: Chronic lymphoid leukemia, in relapse### Assistant: 20412 |
### Human: Subacute lymphoid leukemia, without mention of having achieved remission### Assistant: 20420 |
### Human: Subacute lymphoid leukemia, in remission### Assistant: 20421 |
### Human: Subacute lymphoid leukemia, in relapse### Assistant: 20422 |
### Human: Other lymphoid leukemia, without mention of having achieved remission### Assistant: 20480 |
### Human: Other lymphoid leukemia, in remission### Assistant: 20481 |
### Human: Other lymphoid leukemia, in relapse### Assistant: 20482 |
### Human: Unspecified lymphoid leukemia, without mention of having achieved remission### Assistant: 20490 |
### Human: Unspecified lymphoid leukemia, in remission### Assistant: 20491 |
### Human: Unspecified lymphoid leukemia, in relapse### Assistant: 20492 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.